Interim Report - January – September, 2019 Redsense Medical AB (publ)
Quarter 3, 2019, showed an increase in sales of 103% versus same period last year and is the strongest in the company’s history. The growth is driven by the US market.Financial Summary Third quarter, 1 July – 30 September 2019 Redsense Medical group · Sales amounted to 4 645 KSEK (2 286), with an increase of 103% compared to 2018. · Earnings before interest and taxes amounted to -590 KSEK (-970). Redsense Medical AB · Net sales amounted to 3 257 KSEK (1 871). · Earnings before interest and taxes amounted to -895 KSEK (-530). 1 January – 30 September 2019